Contact
 

A Glimpse at our HIV Vaccine History

In a brief history of the global effort to develop a preventive HIV vaccine (Vaccine 2013, in press), Enterprise champion, Jose Esparza has set down the highs and lows of 30 years of research and development on HIV vaccines that have brought us where we are today. This is an important contribution because many senior HIV vaccine scientists have forgotten what we did and why we did it and, conversely, many younger scientists are not aware of those past efforts.  It would be a serious mistake to forget those lessons from the past or not to share our joint history with those outside the field. We all need to understand the scope of the challenge, and the ways in which we’ve moved forward and improved our understanding. 

You’ll learn, hopefully, that what we’re doing now is smarter based on what we’ve learned, and also somewhat forgetful about what we tried and what happened, often unexpectedly in the past. Without that perspective it will be difficult to appreciate how many plans there have been and how hard they’ve been to realize.

Here is the link to Dr. Esparza’s brief, wise history, http://www.sciencedirect.com/science/article/pii/S0264410X13005963. In the conclusion, he makes the case that a broader view and more collaboration are the best path to an effective vaccine, especially through the Global HIV Vaccine Enterprise.

Esparza J. A brief history of the global effort to develop a preventive HIV vaccine. Vaccine (2013), http://dx.doi.org/10.1016/j.vaccine.2013.05.018 

Bill Snow, Enterprise Director

Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account